Zoltan Szilvassy

Title: Zoltan Szilvassy: Innovator in Pharmaceutical Composition

Introduction

Zoltan Szilvassy is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastrointestinal motility disorders. His innovative approach has led to the development of a unique pharmaceutical composition that addresses various gastrointestinal issues.

Latest Patents

Zoltan Szilvassy holds 1 patent for his invention titled "Pharmaceutical composition having prokinetic effect." This patent focuses on a method for treating gastrointestinal motility disorders in subjects in need. The method involves administering a therapeutically effective amount of O-(3-piperidino-2-hydroxypropyl) nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof. The gastrointestinal motility disorders targeted by this invention include reflux esophagitis, type II and type III biliary and pancreatic sphincter of Oddi dysfunction, postcholecystectomy syndrome, non-ulcerative colitis, and fecal incontinence.

Career Highlights

Throughout his career, Zoltan Szilvassy has worked with various organizations, including N-Gene Research Laboratories, Inc. and Peter Literati Nagy. His work in these companies has allowed him to collaborate with other professionals in the field and contribute to advancements in pharmaceutical research.

Collaborations

Some of Zoltan Szilvassy's notable coworkers include Peter Literati Nagy and Kálmán Tory. Their collaborative efforts have played a role in the development of innovative solutions in the pharmaceutical industry.

Conclusion

Zoltan Szilvassy's contributions to the field of pharmaceuticals, particularly through his patent for a prokinetic pharmaceutical composition, highlight his role as an innovator. His work continues to impact the treatment of gastrointestinal motility disorders, showcasing the importance of innovation in healthcare.